151 related articles for article (PubMed ID: 3873867)
1. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
3. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Gomes JA; Hariman RJ; Kang PS; Chowdry IH
J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D
Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906
[TBL] [Abstract][Full Text] [Related]
5. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
[TBL] [Abstract][Full Text] [Related]
6. Effects of ajmaline on rate-dependent atrioventricular node properties. Potential role in experimental atrioventricular re-entrant tachycardia.
Nayebpour M; Naseri M; Khori V
Eur J Pharmacol; 2001 Jan; 412(1):77-89. PubMed ID: 11166739
[TBL] [Abstract][Full Text] [Related]
7. The prophylaxis of AV nodal re-entry tachycardia.
Tonkin AM; Shorne L
Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic characteristics of verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus.
Yamabe H; Tanaka Y; Okumura K; Morikami Y; Kimura Y; Hokamura Y; Ogawa H
Am J Cardiol; 2005 Jun; 95(12):1425-30. PubMed ID: 15950564
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
Chen X; Borggrefe M; Martinez-Rubio A; Hief C; Haverkamp W; Hindricks G; Breithardt G
J Cardiovasc Pharmacol; 1994 Oct; 24(4):664-9. PubMed ID: 7528850
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic treatment of atrioventricular tachycardias.
Goy JJ; Fromer M
J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S36-40. PubMed ID: 1723116
[TBL] [Abstract][Full Text] [Related]
11. Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia.
Reddy CP; McAllister RG
Am J Cardiol; 1984 Sep; 54(6):535-43. PubMed ID: 6475770
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of simvastatin to terminate fast reentrant tachycardia through increasing wavelength of atrioventricular nodal reentrant tachycardia circuit.
Khori V; Alizadeh AM; Moheimani HR; Zahedi M; Aminolsharieh Najafi S; Shakiba D; Nayebpour M
Fundam Clin Pharmacol; 2015 Feb; 29(1):41-53. PubMed ID: 24990322
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous AV nodal reentrant and ventricular tachycardias.
Belhassen B; Pelleg A; Paredes A; Laniado S
Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):325-31. PubMed ID: 6204282
[TBL] [Abstract][Full Text] [Related]
15. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
Tonkin AM; Aylward PE; Joel SE; Heddle WF
J Cardiovasc Pharmacol; 1980; 2(5):473-86. PubMed ID: 6157944
[TBL] [Abstract][Full Text] [Related]
16. Salutary effects of intravenous ajmaline in patients with paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways: blockade of the retrograde fast pathway.
Sethi KK; Jaishankar S; Gupta MP
Circulation; 1984 Nov; 70(5):876-83. PubMed ID: 6488500
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
Belhassen B; Glick A; Laniado S
Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
[TBL] [Abstract][Full Text] [Related]
18. Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction.
Massumi RA; Udhoji VN
J Electrocardiol; 1988 Jan; 21(1):83-8. PubMed ID: 3351414
[TBL] [Abstract][Full Text] [Related]
19. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
Keren G; Tepper D; Butler B; Torres V; Somberg JC
Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
[TBL] [Abstract][Full Text] [Related]
20. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
